ライフサイエンスコーパス: arboviral

1 longest duration in those with fungal (13), arboviral (10), and bacterial meningitis (7).

2 sion rate at 30 days was 3.2%; patients with arboviral (12.7%), bacterial (6.7%), and fungal (5.4%) e

3 ose with bacterial (8.2%), fungal (8.2%), or arboviral (8.9%) disease.

4 ded solution for preventing new outbreaks of arboviral and parasitic diseases in anthropic environmen

5 nd environmental investigations suggested an arboviral cause.

6 -PCR) assay in urine or blood in an enhanced arboviral clinical surveillance site.

7 ue virus, DENV-1-4, are the leading cause of arboviral disease globally.

8 virus (EEEV) produces the most severe human arboviral disease in North America (NA) and is a potenti

9 Dengue is the most prevalent arboviral disease of humans.

10 ular stomatitis is an economically important arboviral disease of livestock.

11 Dengue is an emerging arboviral disease where the severity of illness is influ

12 he development of novel strategies to combat arboviral disease, including the release of transgenic m

13 V) infection is a re-emerging pandemic human arboviral disease.

14 l practical and theoretical tools to control arboviral disease.

15 seen an unprecedented emergence of epidemic arboviral diseases (notably dengue, chikungunya, yellow

16 Many arboviral diseases are uncontrolled, and the viruses tha

17 virus (EEEV) produces the most severe human arboviral diseases in the United States, with mortality

18 For decades, arboviral diseases were considered to be only minor cont

19 tions known to be effective against multiple arboviral diseases will offer the most cost-effective an

20 xciting potential new form of biocontrol for arboviral diseases, including dengue.

21 osquito Aedes aegypti is the major vector of arboviral diseases, particularly of Dengue fever, of whi

22 eting inflammasome function could help treat arboviral diseases.

23 transmits the pathogens of Lyme and several arboviral diseases.

24 r mosquito, Aedes aegypti, a major vector of arboviral diseases.

25 layers in the epidemiology of many important arboviral diseases.

26 s since become one of the best-characterized arboviral diseases.

27 y obligate host alternation and predict that arboviral emergence via host range changes may be less f

28 AC) virus is an important cause of pediatric arboviral encephalitis in the United States.

29 Arboviral encephalitis is a potentially devastating huma

30 WV-infected BALB/c mice demonstrated typical arboviral encephalitis, characterized by paresis and par

31 of this paper is to review lessons from past arboviral epidemics and determine how these observations

32 The accurate forecasting of mosquito-borne arboviral epidemics will help minimize their impact on u

33 n 1999, has been responsible for the largest arboviral epiornitic and epidemic of human encephalitis

34 ved regions in these proteomes, although the arboviral Flaviviridae are a notable exception where non

35 m samples from 346 patients with a suspected arboviral illness were tested using a multiplex real-tim

36 nt assays (ELISAs) for the detection of anti-arboviral immunoglobulin G (IgG ELISAs) were developed f

37 e served as a test of how the probability of arboviral incursion into new regions is assessed and has

38 ophagous nature of mosquitoes contributes to arboviral infection after a blood meal, which suppresses

39 Dengue is the most common arboviral infection of humans, responsible for a substan

40 Dengue is the most common arboviral infection of humans.

41 dicating that GABA signaling facilitates the arboviral infection of mosquitoes.

42 ell response against dengue virus (DenV), an arboviral infection that afflicts >50 million individual

43 Dengue is a arboviral infection that represents a major global healt

44 Dengue virus has emerged as an important arboviral infection worldwide.

45 Consistently, inoculation of GABA enhanced arboviral infection, indicating that GABA signaling faci

46 rtant role in host immune responses early in arboviral infection.

47 serologic and viral testing for evidence of arboviral infection.

48 al protection that reduce the probability of arboviral infection.

49 Arboviral infections are an important cause of emerging

50 in the treatment of LACV and, more broadly, arboviral infections of the central nervous system.

51 health tool for assessing the risk of human arboviral infections, allocating limited public health r

52 diseases that may be rare, or in the case of arboviral infections, often have variable seasonal and g

53 ere standardized for laboratory diagnosis of arboviral infections, with the intent that they be used

54 of Aedes aegypti mosquitoes to disseminated arboviral infections.

55 , West Nile virus has produced the 3 largest arboviral neuroinvasive disease outbreaks ever recorded

56 Research associated with arboviral outbreaks has provided an understanding of the

57 e virus (DENV) is the most significant human arboviral pathogen and causes approximately 400 million

58 In June 2006, bluetongue virus, an arboviral pathogen of ruminants, appeared in northern Eu

59 nt of dual-acting therapeutics against these arboviral pathogens.

60 of the patients but no dengue virus or other arboviral RNA.